OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-240.10%
Operating margin
-1,712.00%
ROE
-17.50%
ROA
-21.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-447000.00 | — | — | — |
| 2015 | $0.00 | $-13.16M | — | — | — |
| 2016 | $0.00 | $-22.41M | — | — | — |
| 2017 | $0.00 | $-64.81M | — | — | — |
| 2018 | $0.00 | $-51.98M | — | — | — |
| 2019 | $0.00 | $-59.26M | — | — | — |
| 2020 | $12.62M | $-80.73M | 100.00% | -645.40% | -639.83% |
| 2021 | $208.38M | $122.83M | 100.00% | 59.61% | 58.95% |
| 2022 | $1.50M | $-51.41M | 100.00% | -3,696.44% | -3,420.95% |
| 2023 | $392000.00 | $-52.34M | 100.00% | -15,122.70% | -13,351.79% |
| 2024 | $566000.00 | $-26.43M | 100.00% | -10,933.75% | -4,670.14% |
| 2025 | $7.25M | $-17.41M | 95.86% | -585.20% | -240.13% |